Relay Therapeutics, Inc. (RLAY) Misses Q3 EPS by 1c

Relay Therapeutics, Inc. (NASDAQ: RLAY) reported Q3 EPS of ($0.43), $0.01 worse than the analyst estimate of ($0.42).

For earnings history and earnings-related data on Relay Therapeutics, Inc. (RLAY) click here.

You May Also Be Interested In

• UGI shares spike on reported KKR bid for the company
• U.S. mulls smaller military presence in Gulf once war ends - WaPo
• Amazon increases Louisiana data center investment to $18 billion